During the past decade, Tom Baker Cancer Centre - Holy Cross Site conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 1 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Tom Baker Cancer Centre - Holy Cross Site" #1 collaborator was "Astellas Pharma Inc" with 2 trials as a collaborator, "Medivation LLC, a wholly owned subsidiary of Pfizer Inc." with 2 trials as a collaborator and "Canadian Cancer Society (CCS)" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Tom Baker Cancer Centre - Holy Cross Site" are "Cancer" (1 trials), "Castration-Resistant Prostate Cancer" (1 trials), "Insomnia" (1 trials) and "Prostate Cancer" (1 trials). Many other conditions were trialed in "Tom Baker Cancer Centre - Holy Cross Site" in a lesser frequency.

Most popular intervention types in "Tom Baker Cancer Centre - Holy Cross Site" are "Drug" (2 trials) and "Behavioral" (1 trials). Other intervention types were less common.

The name of intervention was led by "Enzalutamide" (2 trials), "Placebo" (2 trials), "Cognitive Behavior Therapy" (1 trials) and "Mindfulness-Based Stress Reduction" (1 trials). Other intervention names were less common.

The vast majority of trials in "Tom Baker Cancer Centre - Holy Cross Site" are 2 trials for "Male" genders and 1 trials for "All" genders.

Currently, there are NaN active trials in "Tom Baker Cancer Centre - Holy Cross Site". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Tom Baker Cancer Centre - Holy Cross Site, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Tom Baker Cancer Centre - Holy Cross Site, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".